Factors influencing USgHIFU ablation for adenomyosis with NPVR ≥ 50%

References

• Vercellini P, Viganò P, Somigliana E, et al. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):465–477.
   PubMed Web of Science ®Google Scholar
• Yu O, Schulze-Rath R, Grafton J, et al. Adenomyosis incidence, prevalence and treatment: united States population-based study 2006–2015. Am J Obstet Gynecol. 2020;223(1):94.e1–94.e10.
   PubMed Web of Science ®Google Scholar
• Xiangying H, Lili H, Yifu S. The effect of hysterectomy on ovarian blood supply and endocrine function. Climacteric. 2006;9(4):283–289.
   PubMed Web of Science ®Google Scholar
• Park DS, Kim ML, Song T, et al. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis. Taiwan J Obstet Gynecol. 2015;54(4):412–415.
   PubMed Web of Science ®Google Scholar
• Szubert M, Koziróg E, Olszak O, et al. Adenomyosis and infertility-review of medical and surgical approaches. IJERPH. 2021;18(3):1235.
   Web of Science ®Google Scholar
• Popovic M, Puchner S, Berzaczy D, et al. Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol. 2011;22(7):901–909; quiz 909.
   PubMed Web of Science ®Google Scholar
• Goodwin SC, Spies JB, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID registry. Obstet Gynecol. 2008;111(1):22–33.
   PubMed Web of Science ®Google Scholar
• Wood C. Adenomyosis: difficult to diagnose, and difficult to treat. Diagn Ther Endosc. 2001;7(2):89–95.
   PubMedGoogle Scholar
• Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):603–616.
   PubMed Web of Science ®Google Scholar
• Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101(2):472–487.
   PubMed Web of Science ®Google Scholar
• Shui L, Mao S, Wu Q, et al. High-intensity focused ultrasound (HIFU) for adenomyosis: two-year follow-up results. Ultrason Sonochem. 2015;27:677–681.
   PubMed Web of Science ®Google Scholar
• Lee JS, Hong GY, Park BJ, et al. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: a single center experience from the Republic Of Korea. Ultrason Sonochem. 2015;27:682–687.
   PubMed Web of Science ®Google Scholar
• Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011;95(3):900–905.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang W, Wang Y, et al. Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study. Medicine (Baltimore). 2016;95(3):e2443.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110(2 Pt 1):279–287.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM, Nadarajan C, et al. Volumetric MRI-guided, high-intensity focused ultrasound ablation of uterine leiomyomas: ASEAN preliminary experience. Diagn Interv Radiol. 2020;26(3):207–215.
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim YS, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231–239.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li K, Xie B, et al. Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound. Int J Gynaecol Obstet. 2014;124(3):207–211.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM. Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis. Int J Hyperthermia. 2018;35(1):626–636.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM. The role of T1 perfusion-based classification in predicting the outcome of magnetic resonance-guided high-intensity focused ultrasound treatment of adenomyosis. Int J Hyperthermia. 2018;34(3):306–314.
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Dorta M, et al. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil Steril. 1992;58(1):94–97.
   PubMed Web of Science ®Google Scholar
• Gong C, Wang Y, Lv F, et al. Evaluation of high intensity focused ultrasound treatment for different types of adenomyosis based on magnetic resonance imaging classification. Int J Hyperthermia. 2022;39(1):530–538.
   PubMed Web of Science ®Google Scholar
• Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020;26(3):392–411.
   PubMed Web of Science ®Google Scholar
• Kishi Y, Suginami H, Kuramori R, et al. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification. Am J Obstet Gynecol. 2012;207(2):114.e1–114.e1147.
   PubMed Web of Science ®Google Scholar
• Peng S, Zhang L, Hu L, et al. Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study. Medicine (Baltimore). 2015;94(13):e650.
   PubMed Web of Science ®Google Scholar
• Park H, Yoon SW, Sokolov A. Scaled signal intensity of uterine fibroids based on T2-weighted MR images: a potential objective method to determine the suitability for magnetic resonance-guided focused ultrasound surgery of uterine fibroids. Eur Radiol. 2015;25(12):3455–3458.
   PubMed Web of Science ®Google Scholar
• Jiang L, Yu JW, Yang MJ, et al. Ultrasound-guided HIFU for uterine fibroids of hyperintense on T2-weighted MR imaging with or without GnRH-analogue-pretreated: a propensity score matched cohort study. Front Surg. 2022;9:975839.
   PubMed Web of Science ®Google Scholar
• Goodwin SC, Bonilla SC, Sacks D, et al. Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol. 2003;14(9 Pt 2):S467–S476.
   PubMed Web of Science ®Google Scholar
• Lee JS, Hong GY, Lee KH, et al. Safety and efficacy of Ultrasound-Guided High-Intensity focused ultrasound treatment for uterine fibroids and adenomyosis. Ultrasound Med Biol. 2019;45(12):3214–3221.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2018;125(3):354–364.
   PubMed Web of Science ®Google Scholar
• Zhang C, Jacobson H, Ngobese ZE, et al. Efficacy and safety of ultrasound-guided high intensity focused ultrasound ablation of symptomatic uterine fibroids in black women: a preliminary study. BJOG. 2017;124(Suppl 3):12–17.
   PubMedGoogle Scholar
• Du CC, Wang YQ, Qu DC, et al. Magnetic resonance imaging T2WI hyperintense foci number and the prognosis of adenomyosis after high-intensity focused ultrasound treatment. Int J Gynaecol Obstet. 2021;154(2):241–247.
   PubMed Web of Science ®Google Scholar
• Jeng CJ, Ou KY, Long CY, et al. 500 Cases of high-intensity focused ultrasound (HIFU) ablated uterine fibroids and adenomyosis. Taiwan J Obstet Gynecol. 2020;59(6):865–871.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Li Q, Li W, et al. A comparative analysis of pregnancy outcomes of patients with uterine fibroids after high intensity focused ultrasound ablation and laparoscopic myomectomy: a retrospective study. Int J Hyperthermia. 2021;38(1):79–84.
   PubMed Web of Science ®Google Scholar
• Liu Z, Gong C, Liu Y, et al. Establishment of a scoring system for predicting the difficulty level of high-intensity focussed ultrasound ablation of uterine fibroids. Int J Hyperthermia. 2018;34(1):77–86.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM. Magnetic resonance imaging parameters in predicting the treatment outcome of high-intensity focused ultrasound ablation of uterine fibroids with an immediate nonperfused volume ratio of at least 90. Acad Radiol. 2018;25(10):1257–1269.
   PubMed Web of Science ®Google Scholar
• Feng Y, Hu L, Chen W, et al. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: a retrospective cohort study. Ultrason Sonochem. 2017;36:139–145.
   PubMed Web of Science ®Google Scholar
• Sample WF, Lippe BM, Gyepes MT. Gray-scale ultrasonography of the normal female pelvis. Radiology. 1977;125(2):477–483.
   PubMed Web of Science ®Google Scholar
• Koike H, Egawa H, Ohtsuka T, et al. Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis. Prostaglandins Leukot Essent Fatty Acids. 1992;46(2):133–137.
   PubMed Web of Science ®Google Scholar
• Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21(6):762–778.
   PubMed Web of Science ®Google Scholar
• Gong C, Yang B, Shi Y, et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study. Int J Hyperthermia. 2016;32(5):496–503.
   PubMed Web of Science ®Google Scholar
• Fan HJ, Zhang C, Lei HT, et al. Ultrasound-guided high-intensity focused ultrasound in the treatment of uterine fibroids. Medicine (Baltimore). 2019;98(10):e14566.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Chen WZ. Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images. Exp Ther Med. 2016;11(1):328–334.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Yue Y, Shui L, et al. Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: a retrospective study. Int J Hyperthermia. 2015;31(7):777–783.
   PubMed Web of Science ®Google Scholar
• Shimada K, Ohashi I, Kasahara I, et al. Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs. diffusion-weighted MRI with very small b-factors. J Magn Reson Imaging. 2004;20(1):97–104.
   PubMed Web of Science ®Google Scholar
• Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003;17(5):509–520.
   PubMed Web of Science ®Google Scholar
• Burbank F. Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology? J Am Assoc Gynecol Laparosc. 2004;11(2):138–152.
   PubMedGoogle Scholar
• Delli Carpini G, Morini S, Papiccio M, et al. The association between childbirth, breastfeeding, and uterine fibroids: an observational study. Sci Rep. 2019;9(1):10117.
   PubMedGoogle Scholar
• Gong C, Setzen R, Liu Z, et al. High intensity focused ultrasound treatment of adenomyosis: the relationship between the features of magnetic resonance imaging on T2 weighted images and the therapeutic efficacy. Eur J Radiol. 2017;89:117–122.
   PubMed Web of Science ®Google Scholar
• Antero MF, Ayhan A, Segars J, et al. Pathology and pathogenesis of adenomyosis. Semin Reprod Med. 2020;38(2-03):108–118.
   PubMed Web of Science ®Google Scholar
• Yin N, Hu L, Xiao ZB, et al. Factors influencing thermal injury to skin and abdominal wall structures in HIFU ablation of uterine fibroids. Int J Hyperthermia. 2018;34(8):1298–1303.
   PubMed Web of Science ®Google Scholar